Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › &agr;-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders

&agr;-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders

US Patent 6417229 · Granted Jul 9, 2002

Estimated economic value: $222,733,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazole derivatives2006
Muscarinic receptor agonists2005
Heterocyclic-cyclic amine derivatives as cholinesterase inhibitors2002
Heterocyclic-cyclic amine derivatives2001
Muscarinic receptor agonists2000
Processes and intermediates for preparing 5, 7-dihydro-3-2-(1-benzylpiperidin-4-1999
Acyclic anc cyclic amides as neurotransmitter release enhancers1998
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors1998
Methods of using piperidyl-benzisoxazole and benisothiazole derivatives as choli1996